MESSINA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 569
AS - Asia 78
EU - Europa 61
SA - Sud America 1
Totale 709
Nazione #
US - Stati Uniti d'America 566
SG - Singapore 41
CN - Cina 34
IT - Italia 22
FR - Francia 12
GB - Regno Unito 8
DE - Germania 7
CA - Canada 3
FI - Finlandia 3
IE - Irlanda 3
IN - India 2
RU - Federazione Russa 2
AM - Armenia 1
BE - Belgio 1
CL - Cile 1
LT - Lituania 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 709
Città #
Fairfield 98
Santa Clara 49
Ashburn 48
Chandler 48
Cambridge 39
Houston 34
Singapore 34
Seattle 31
Wilmington 30
Woodbridge 26
New York 18
Ann Arbor 13
Boardman 13
Medford 11
Princeton 11
Beijing 9
Des Moines 7
Roxbury 6
San Diego 6
Padova 4
Battaglia Terme 3
Dublin 3
Helsinki 3
London 3
Shenyang 3
Toronto 3
Washington 3
Florence 2
Hebei 2
Los Angeles 2
Milan 2
Nantes 2
Naples 2
San Giovanni in Persiceto 2
Bratislava 1
Brussels 1
Dallas 1
Edinburgh 1
Ferentino 1
Jinan 1
Nuremberg 1
Ogden 1
Palermo 1
Pune 1
Rockville 1
Santiago Metropolitan 1
Seacroft 1
Wuxi 1
Yerevan 1
Totale 585
Nome #
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study 133
Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations 91
Comment on: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab 79
Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy 63
Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report 63
Association between melanoma and exposure to sex hormones in puberty: A possible window of susceptibility 51
REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19 46
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study 42
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 40
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 40
Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues 33
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study 22
Trauma of Peripheral Innervation Impairs Content of Epidermal Langerhans Cells 21
null 3
Totale 727
Categoria #
all - tutte 4.121
article - articoli 4.121
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 6 12 20 15 4 10
2020/2021184 2 28 22 12 0 2 0 11 25 10 21 51
2021/2022105 0 1 10 0 5 15 0 4 18 7 8 37
2022/2023104 22 0 0 1 26 20 0 7 18 0 8 2
2023/202488 0 8 12 13 2 26 6 0 7 3 8 3
2024/2025140 2 27 18 16 60 17 0 0 0 0 0 0
Totale 727